Trials / Active Not Recruiting
Active Not RecruitingNCT07359248
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
Study on the Effectiveness of Preventive Treatment With Venlafaxine for Frequent Episodic Tension-type Headache
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 432 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate whether Desvenlafaxine can reduce the frequency and severity of TTH attacks in patients.
Detailed description
This randomized, double-blind, placebo-controlled trial aims to assess the efficacy of Desvenlafaxine (a serotonin-norepinephrine reuptake inhibitor) in reducing the frequency and severity of tension-type headache (TTH) attacks in adult patients with episodic TTH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desvenlafaxine | Desvenlafaxine |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2027-12-31
- Completion
- 2028-01-01
- First posted
- 2026-01-22
- Last updated
- 2026-01-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07359248. Inclusion in this directory is not an endorsement.